Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionTocqueville Asset Management L.p.
Latest Disclosed Ownership60,817 shares
Latest Disclosed Value $ 8,476,065
Tocqueville Asset Management L.p. reports 18.63% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - Tocqueville Asset Management L.p. filed a 13F-HR form disclosing ownership of 60,817 shares of Gilead Sciences, Inc. (US:GILD) valued at $8,476,065 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 74,744 shares of Gilead Sciences, Inc.. This represents a change in shares of -18.63% during the quarter. The current value of the position is $7,844,785 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GILEAD SCIENCES COM 375558103 60,817 -13,927 -18.63 8,476 -7.61 0.1257
2026-02-12 2025-12-31 13F GILEAD SCIENCES COM 375558103 74,744 -21 -0.03 9,174 10.56 0.1338
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 74,765 -16 -0.02 8,299 0.10 0.1206
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 74,781 399 0.54 8,291 -0.53 0.1262
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 74,382 -815 -1.08 8,335 20.00 0.1361
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 75,197 -600 -0.79 6,946 9.30 0.1089
2024-11-08 2024-09-30 13F GILEAD SCIENCES COM 375558103 75,797 -6,105 -7.45 6,355 13.08 0.0998
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 81,902 -9,953 -10.84 5,619 -16.48 0.0928
2024-05-09 2024-03-31 13F GILEAD SCIENCES COM 375558103 91,855 -693 -0.75 6,728 -10.26 0.1099
2024-02-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 92,548 -1,407 -1.50 7,497 6.49 0.1359
2023-11-09 2023-09-30 13F GILEAD SCIENCES COM 375558103 93,955 166 0.18 7,041 -2.60 0.1337
2023-08-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 93,789 -827 -0.87 7,228 -7.92 0.1294
2023-05-10 2023-03-31 13F GILEAD SCIENCES COM 375558103 94,616 225 0.24 7,850 -3.12 0.1483
2023-02-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 94,391 -48,715 -34.04 8,103 -8.21 0.1539
2022-11-10 2022-09-30 13F GILEAD SCIENCES COM 375558103 143,106 16,905 13.40 8,828 13.18 0.1799
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 126,201 -6,200 -4.68 7,800 -0.90 0.1426
2022-05-16 2022-03-31 13F Gilead Sciences COM 375558103 132,401 -45,023 -25.38 7,871 -38.90 0.1189
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 177,424 -158,975 -47.26 12,883 -45.17 0.1772
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 336,399 55 0.02 23,497 1.45 0.3481
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 336,344 9,995 3.06 23,161 9.81 0.3346
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 326,349 315,154 2,815.13 21,092 3,134.97 0.3245
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 11,195 -1,600 -12.50 652 -19.41 0.0109
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 12,795 -15,047 -54.04 809 -62.23 0.0155
2020-08-12 2020-06-30 13F GILEAD SCIENCES COM 375558103 27,842 -8,215 -22.78 2,142 -20.55 0.0447
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 36,057 -1,562 -4.15 2,696 10.31 0.0670
2020-01-14 2019-12-31 13F Gilead Sciences COM 375558103 37,619 -3,197 -7.83 2,444 -5.53 0.0359
2019-10-31 2019-09-30 13F Gilead Sciences COM 375558103 40,816 -675 -1.63 2,587 -7.71 0.0351
2019-07-31 2019-06-30 13F Gilead Sciences COM 375558103 41,491 -50 -0.12 2,803 3.78 0.0363
2019-04-30 2019-03-31 13F Gilead Sciences COM 375558103 41,541 -23,282 -35.92 2,701 -33.39 0.0361
2019-02-08 2018-12-31 13F Gilead Sciences COM 375558103 64,823 -14,304 -18.08 4,055 -33.62 0.0608
2018-11-13 2018-09-30 13F Gilead Sciences COM 375558103 79,127 -667 -0.84 6,109 8.07 0.0770
2018-08-13 2018-06-30 13F Gilead Sciences COM 375558103 79,794 175 0.22 5,653 -5.81 0.0717
2018-05-14 2018-03-31 13F Gilead Sciences COM 375558103 79,619 -7,098 -8.19 6,002 -3.38 0.0765
2018-02-13 2017-12-31 13F Gilead Sciences COM 375558103 86,717 -41,212 -32.21 6,212 -40.07 0.0705
2017-10-30 2017-09-30 13F Gilead Sciences COM 375558103 127,929 92,796 264.13 10,365 316.77 0.1192
2017-08-04 2017-06-30 13F Gilead Sciences COM 375558103 35,133 757 2.20 2,487 6.51 0.0298
2017-04-28 2017-03-31 13F Gilead Sciences COM 375558103 34,376 -64,931 -65.38 2,335 -67.16 0.0285
2017-01-30 2016-12-31 13F Gilead Sciences COM 375558103 99,307 -43,367 -30.40 7,111 -37.00 0.0909
2016-10-31 2016-09-30 13F Gilead Sciences COM 375558103 142,674 -85,317 -37.42 11,288 -40.65 0.1355
2016-08-15 2016-06-30 13F/A-1 Gilead Sciences COM 375558103 227,991 -21,047 -8.45 19,019 -16.86 0.2266
2016-07-29 2016-06-30 13F Gilead Sciences COM 375558103 227,991 19,019
2016-04-29 2016-03-31 13F Gilead Sciences COM 375558103 249,038 3,070 1.25 22,877 -8.09 0.3030
2016-01-29 2015-12-31 13F Gilead Sciences COM 375558103 245,968 1,763 0.72 24,890 3.80 0.3374
2015-10-30 2015-09-30 13F Gilead Sciences COM 375558103 244,205 -931 -0.38 23,978 -16.46 0.3208
2015-07-31 2015-06-30 13F Gilead Sciences COM 375558103 245,136 11,108 4.75 28,701 24.98 0.3380
2015-04-30 2015-03-31 13F Gilead Sciences COM 375558103 234,028 234,028 0.00 22,965 0.2699
2015-01-30 2014-12-31 13F Gilead Sciences COM 375558103 0 -266,220 -100.00 0 -100.00
2014-10-30 2014-09-30 13F Gilead Sciences COM 375558103 266,220 -1,313 -0.49 28,339 27.76 0.3145
2014-09-18 2014-06-30 13F/A-1 Gilead Sciences COM 375558103 267,533 -1,506 -0.56 22,181 16.35 0.2159
2014-07-30 2014-06-30 13F Gilead Sciences COM 375558103 267,533 22,181
2014-04-30 2014-03-31 13F Gilead Sciences COM 375558103 269,039 18,779 7.50 19,064 1.43 0.2509
2014-01-30 2013-12-31 13F Gilead Sciences COM 375558103 250,260 2,344 0.95 18,795 20.59 0.2527
2013-10-30 2013-09-30 13F Gilead Sciences COM 375558103 247,916 14,201 6.08 15,586 30.07 0.1943
2013-07-30 2013-06-30 13F Gilead Sciences COM 375558103 233,715 233,715 11,983 0.1622
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.